Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
32 hedge funds and large institutions have $28.5M invested in Zosano Pharma Corporation in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 11 closing their positions.
1,685% more capital invested
Capital invested by funds: $1.59M → $28.5M (+$26.9M)
136% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 11
88% more funds holding
Funds holding: 17 → 32 (+15)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.56M |
| 2 |
NC
Nexthera Capital
New York
|
+$6.69M |
| 3 |
HM
HealthCor Management
New York
|
+$5.26M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
+$4.78M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$4.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$260K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$134K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$97K |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$54K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$42K |
ZSAN Hedge Fund Activity: Q1 2018 in Review
32 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2018, worth a combined $28.5M — up 1,685% from $1.59M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ZSAN positions and 11 closed out — a net gain of 15 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $9.56M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $260K sold.
- 32 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2018, up from 17 in Q4 2017.
- Funds reported $28.5M of Zosano Pharma Corporation stock for Q1 2018, up 1,685% quarter-over-quarter.
- 26 funds opened new Zosano Pharma Corporation positions in Q1 2018 and 11 closed out, a net change of +15 holders.
- The largest Zosano Pharma Corporation buyer in Q1 2018 was Adage Capital Partners, an estimated $9.56M added.
- The largest Zosano Pharma Corporation seller in Q1 2018 was Perceptive Advisors, an estimated $260K sold.
Based on aggregated 13F filings for Q1 2018.